A Massachusetts federal judge determined the court lacked personal jurisdiction over a COVID-19 vaccine patent case, transferring the matter to Virginia.
Judge Nathaniel M. Gorton for the District of Massachusetts transferred an action filed by Pfizer and BioNTech seeking declaratory judgment that they don’t infringe certain patents of CureVac AG relating to the COVID-19 vaccine to the Eastern District of Virginia, after determining the court lacked jurisdiction.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
